Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
388
datasets available to search
ShareScore release 0.9.0
Dataset results
388 results for “immune checkpoint inhibitors”
Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors
ClinicalTrials.gov study NCT05320640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04751396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
JAK Inhibitors for Solid Malignant Tumor Patients With Immune Checkpoint Inhibitors-related Dermatitis: A Open-lable, Single Arm, Phase IIa Trial
ClinicalTrials.gov study NCT06715982. IPD Sharing: YES. Countries: 1. Publications: 0.
SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT07341321. IPD Sharing: YES. Countries: 1. Publications: 0.
Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab
ClinicalTrials.gov study NCT03612791. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer
ClinicalTrials.gov study NCT07231445. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT03946007. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
ClinicalTrials.gov study NCT05714371. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites
ClinicalTrials.gov study NCT06759064. IPD Sharing: NO. Countries: 1. Publications: 0.
Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study
ClinicalTrials.gov study NCT07004868. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis
ClinicalTrials.gov study NCT05062395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05544149. IPD Sharing: NO. Countries: 1. Publications: 0.
Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside
ClinicalTrials.gov study NCT06020651. IPD Sharing: NO. Countries: 1. Publications: 0.
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
ClinicalTrials.gov study NCT06422403. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05653531. IPD Sharing: NO. Countries: 1. Publications: 0.
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors
ClinicalTrials.gov study NCT05967533. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
ClinicalTrials.gov study NCT04407247. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
ClinicalTrials.gov study NCT06107608. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT06581406. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients
ClinicalTrials.gov study NCT07191171. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.